Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • metropath metropath May 22, 2013 9:58 AM Flag

    marketing Cabo

    MM mentioned marketing Cabo to non-academic oncologists for MTC.
    This is a smart move! I have seen in the past that Xgeva (Amgen), Provenge, and most recent Zytiga (abi) send their sale rep to urology offices trying very hard to expend ther mCRPC market share.

    Sentiment: Strong Buy

 
EXEL
2.76-0.07(-2.47%)4:00 PMEDT